Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00444665
Status:
COMPLETED
Last Update Posted:
2016-11-21
First Post:
2007-03-07
Brief Title:
Examining The Efficacy Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution Travatan-Z Compared To Prior Prostaglandin Therapy
Sponsor:
Alcon Research
Organization:
Alcon Research
Study Overview
Official Title:
Examining The Efficacy Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution Travatan-Z Compared To Prior Prostaglandin Therapy
Status:
COMPLETED
Status Verified Date:
2008-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Examine the safety tolerability and efficacy of travoprost benzalkonium chloride BAK free ophthalmic solution compared to either latanoprost or bimatoprost monotherapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None